You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 23, 2025

Drug Price Trends for FT IBUPROFEN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FT IBUPROFEN

Average Pharmacy Cost for FT IBUPROFEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FT IBUPROFEN 200 MG CAPLET 70677-1136-02 0.03291 EACH 2025-03-19
FT IBUPROFEN 200 MG MINI SFGL 70677-1113-01 0.07773 EACH 2025-03-19
FT IBUPROFEN 200 MG SOFTGEL 70677-1114-01 0.07773 EACH 2025-03-19
FT IBUPROFEN 200 MG CAPLET 70677-1136-03 0.03291 EACH 2025-03-19
FT IBUPROFEN PM 200-38 MG CPLT 70677-1131-01 0.12790 EACH 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Global Ibuprofen Market Analysis and Price Projections

Introduction to Ibuprofen

Ibuprofen, a widely used non-steroidal anti-inflammatory drug (NSAID), is a staple in both prescription and over-the-counter (OTC) medication markets. It is used to treat a variety of conditions, including pain, inflammation, and fever. Here’s a comprehensive analysis of the global ibuprofen market, including its current state, growth drivers, and future projections.

Global Ibuprofen Market Size and Growth

The global ibuprofen market is experiencing steady growth driven by several key factors.

  • Current Market Size: As of 2023, the global ibuprofen market was valued at USD 1.43 billion[1].
  • Forecasted Growth: It is estimated to reach USD 1.76 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 2.44% during the forecast period (2024–2032)[1].

Regional Market Analysis

The ibuprofen market is segmented into several regions, each with its own growth dynamics.

  • Asia Pacific: This region holds the largest share of the global ibuprofen market. The cost-efficient manufacturing of pharmaceuticals in countries like China and India, along with rising healthcare expenditures, significantly contribute to this dominance. For instance, India's aging population, with approximately 137.9 million Indians aged over 60 in 2021, is expected to increase to 193.8 million by 2031, driving the demand for pain management solutions like ibuprofen[1].
  • North America: This region is identified as the fastest-growing market for ibuprofen. The growing adoption of self-medication and the easy availability of OTC pain relief solutions are key drivers here[1][2].

Drivers of Market Growth

Several factors are contributing to the growth of the global ibuprofen market.

  • Rising Healthcare Expenditures: Increasing healthcare spending, particularly in the Asia Pacific region, is a significant driver. Healthcare benefit cost trends in this region have been rising, from over 5% in 2020 to nearly 8% in 2021, and are projected to continue this upward trend[1].
  • Self-Medication Trend: The growing preference for self-medication and the use of OTC medications for minor ailments are boosting the demand for ibuprofen. Consumers are increasingly relying on online pharmacies and healthcare information sources to manage their health independently[2].
  • Chronic Diseases: Rising public awareness of chronic diseases such as rheumatoid arthritis, osteoarthritis, headaches, and cardiovascular disease also drives the demand for ibuprofen[1].

Ibuprofen API Market

The ibuprofen Active Pharmaceutical Ingredient (API) market is another crucial segment.

  • Current Market Size: The ibuprofen API market was valued at over USD 715.08 million in 2024[3][4].
  • Forecasted Growth: It is expected to cross USD 936.89 million by 2037, growing at a CAGR of more than 2.1% during the forecast period (2025–2037)[3][4].
  • Influence of Influenza: The surge in prevalence of influenza, with approximately a billion instances annually, is expected to increase the demand for ibuprofen API, particularly when used in combination with acetaminophen to relieve symptoms like headaches and muscle aches[3][4].

Price Projections

Price dynamics in the ibuprofen market are influenced by various factors, including regulatory changes and market demand.

  • Recent Price Adjustments: Effective April 1, 2024, the National Pharmaceutical Pricing Authority (NPPA) announced a minor increase in the Maximum Retail Price (MRP) of prescription drugs, including ibuprofen, by 0.00551 percent[1].
  • Future Projections: The overall market growth and increasing demand are expected to stabilize prices, although regional variations may occur due to differences in production costs and healthcare regulations. For instance, the ibuprofen API market is projected to reach USD 851 million by 2034, growing at a CAGR of 2.5%[5].

Strategic Initiatives by Industry Players

Key industry players are implementing various strategies to enhance market growth.

  • Investments and Expansions: Companies like IOL Chemicals & Pharmaceuticals are investing heavily in capital expenditures to establish new plants and diversify their portfolios. For example, IOL Chemicals & Pharmaceuticals announced an investment of INR 300 crore to establish a plant in western India, which is expected to bolster the country's market share[1].
  • Partnerships and Acquisitions: Strategic partnerships and acquisitions are also driving market growth by expanding product offerings and improving manufacturing efficiencies[1].

Market Segmentation

The global ibuprofen market is segmented based on several criteria.

  • Dosage Form: The market is segmented into various dosage forms such as tablets, capsules, and suspensions.
  • Type: It includes prescription and OTC segments.
  • End-User: The market is segmented into hospitals, clinics, and retail pharmacies.
  • Application: Ibuprofen is used in treating various conditions including pain relief, inflammation, and fever[1].

Consumer Behavior and Trends

Consumer behavior plays a crucial role in shaping the ibuprofen market.

  • Self-Care and Self-Medication: The trend towards self-care and self-medication is significantly boosting the demand for ibuprofen. Consumers are increasingly preferring OTC pain relief solutions for minor ailments, reducing the need for medical consultations[2].
  • Online Pharmacies: The proliferation of online pharmacies and healthcare information sources is empowering individuals to manage their health independently, further driving the market growth[2].

Regulatory Environment

Regulatory changes can impact the ibuprofen market significantly.

  • Price Controls: Regulatory bodies like the NPPA in India have announced minor price increases for prescription drugs, including ibuprofen, which can influence market dynamics[1].
  • Healthcare Regulations: Evolving healthcare regulations, especially in emerging economies, are compelling market growth in the API sector[5].

Key Takeaways

  • The global ibuprofen market is valued at USD 1.43 billion as of 2023 and is expected to reach USD 1.76 billion by 2032.
  • The Asia Pacific region holds the largest market share, driven by cost-efficient manufacturing and rising healthcare expenditures.
  • The trend towards self-medication and increasing healthcare awareness are key drivers of market growth.
  • The ibuprofen API market is expected to grow at a CAGR of more than 2.1% from 2025 to 2037.
  • Strategic initiatives by industry players, such as investments and partnerships, are enhancing market growth.

FAQs

What is the current size of the global ibuprofen market?

The global ibuprofen market was valued at USD 1.43 billion in 2023[1].

Which region has the largest share of the ibuprofen market?

The Asia Pacific region holds the largest share of the global ibuprofen market[1].

What is driving the growth of the ibuprofen market?

The growth is driven by factors such as rising healthcare expenditures, the trend towards self-medication, and increasing public awareness of chronic diseases[1][2].

How is the ibuprofen API market expected to grow?

The ibuprofen API market is expected to grow at a CAGR of more than 2.1% from 2025 to 2037, reaching USD 936.89 million by 2037[3][4].

What impact do regulatory changes have on the ibuprofen market?

Regulatory changes, such as price controls and evolving healthcare regulations, can influence market dynamics and prices. For example, the NPPA announced a minor price increase for prescription drugs, including ibuprofen, in 2024[1].

Sources

  1. Straits Research: Global Ibuprofen Market Size, Top Share, CAGR of 2.44%, Report ...
  2. Cognitive Market Research: Global Ibuprofen Market Report
  3. Research Nester: Ibuprofen API Market Size & Share, Growth Trends 2037
  4. Research Nester: Ibuprofen API Market Size
  5. GlobeNewswire: Ibuprofen API Market Evolution Mapping Growth Trajectory to US$ 851 Million by 2034

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.